There is substantial evidence that high-intensity psychological interventions, such as therapist delivered cognitive behaviour therapy (CBT), are effective for a wide range of mental health problems. However, high-intensity psychological treatments delivered by a highly trained mental health professional in a one-to-one format over a long period of time are resource intensive and have limited availability in the NHS.
Low-intensity psychological therapies differ from high-intensity psychological treatments in that they tend to use less complex treatments, are often shorter in duration, and can be delivered by people who do not have high-intensity training qualifications. If these less resource intensive treatments are clinically and cost-effective, they may be able to increase the availability of psychological treatments in the NHS.
A core research activity of the Mental Health and Addictions Research Group (MHARG) is to evaluate the clinical and cost-effectiveness of these low-intensity treatments in the form of randomised trials and evidence syntheses. Researchers within this theme also apply start-of-the-art methodological and statistical approaches to large routine-practice datasets of services that deliver brief treatments (such as the Improving Access to Psychological Therapies initiative) to examine questions of clinical effectiveness, cost-effectiveness and equity.
The BALM Programme aims to develop, deliver and evaluate a gender-sensitised Behavioural Activation programme as an early intervention for low mood and anxiety in male frontline NHS workers.
The study aims to evaluate the delivery of brief psychological support via community pharmacies to people living with long-term health conditions who will be at an increased risk of developing depression.
The COBRA trial will compare the cost and the outcome of the therapies in order to find out which one of the treatments will be most useful for the treatment of depression.
In this study we will conduct a large scale randomised trial of the effectiveness of screening and low intensity psychosocial interventions for older people (over 65s) with moderate to severe depression.
The SHARD Trial examined a self-help booklet for older people with subthreshold (low severity) depression. Funded by the National Institute for Health Research.
In this study we conducted a randomised controlled trial looking at the clinical and cost effectiveness of a “bespoke smoking cessation” intervention for people with severe mental ill health such as schizophrenia or bipolar disorder.
In this study we will conduct a randomised trial looking at the clinical and cost effectiveness of two self-help treatments (Guided Self-Help and Computerised CBT) compared to a waiting list control for people with OCD.
The CASPER trial examined a treatment called Collaborative Care for older people with subthreshold (low severity) depression. We are currently carrying out an extended follow-up with participants from the CASPER Trial.
Funded by: National Institute for Health Research HTA.
REEACT is a randomised controlled trial which aims to compare two types of computerised cognitive behaviour therapy (CBT) packages (one free-to-use and one commercial) to see if there are any additional benefits of offering this treatment to the care that people already receive from their GP.
The aim of this study is to find out whether psychological therapies are effective for people with substance misuse. This study will investigate how many people with substance use problems and depression are willing to engage with brief psychological therapy, how many complete this, and what participants think about this psychological treatment. We also want to find out if participants who benefit from treatment have certain things in common; for example their use of alcohol or drugs or their level of dependence on substances.
Attachment, the relationship between caregiver and child, is a crucial factor in an infant's ability to develop healthy relationships. Research has identified different types of attachment relationships.